The UK government is considering a proposal to allow up to 5,000 general practitioners to sell over-the-counter drugs in remote parts of the country where pharmacy services are limited. Norman Lamb, a spokesman for the opposition Liberal Democrat party, denounced the idea as "potentially dangerous," adding that it could "risk undermining the fundamental relationship between GP and patient."
Under current rules, some doctors are allowed to dispense prescription drugs, collecting the appropriate fees from the National Health Service. The change being examined would mean that OTC products could be bought without a consultation, with the profits "benefit[ing] local health services."
However, the General Medical Council, which would investigate complaints against individual doctors, told the Marketletter that allegations of conflict of interest over the sale of drugs are extremely rare, and that physicians are bound to maintain an "open and honest" relationship with the patient about fincial interests.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze